Direct and indirect T cell priming by dendritic cell vaccines

European Journal of Immunology

Volumn 29, Issue 1, 1999, Pages 225-234

  Cayeux, Sophie ^a,b   Richter, Günther ^a   Becker, Christian ^a   Pezzutto, Antonio ^b   Dörken, Bernd ^b   Blankenstein, Thomas ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Dendritic cell; T cell priming; Tumor vaccine

Indexed keywords

BETA GALACTOSIDASE; TUMOR VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HAPLOTYPE; IMMUNIZATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, LY; BETA-GALACTOSIDASE; CANCER VACCINES; DENDRITIC CELLS; FEMALE; HAPLOTYPES; IMMUNIZATION; ISOANTIGENS; KILLER CELLS, LYMPHOKINE-ACTIVATED; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032945915     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199901)29:01<225::AID-IMMU225>3.0.CO;2-W     Document Type: Article

References (28)

1. Banchereau, J. and Steinman, R. M., Dendritic cells and the control of immunity. Nature 1998. 392: 245-252.
2. Mayordomo, J. I., Zorina, T., Storkus, W.-J., Zitvogel, L., Celluzzi, C. M., Falo, L. D., Melief, C. J., Ilstad, S. T., Kast, W. M., DeLeo, A. B. and Lotze, M. T., Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nature Med. 1995. 1: 1297-1302.
3. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T. and Storkus, W.-J., Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 1996. 183: 87-97.
4. Porgador, A., Snyder, D. and Gilboa, E., Induction of antitumor immunity using bone marrow-generated dendritic cells. J. Immunol. 1996. 156: 2918-2926.
5. Celluzzi, C. M., Mayordomo, J. I., Storkus, W.-J., Lotze, M. T. and Falo, L. D. Jr., Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 1996. 183: 283-287.
6. Paglia, P., Chiodoni, C., Rodolfo, M. and Colombo, M. P., Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 1996. 183: 317-322.
7. Specht, J. M., Wang, G., Do, M. T., Lam, J. S., Royal, R. E., Reeves, M. E., Rosenberg, S. A. and Hwu, P., Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 1997. 186: 1213-1221.
8. + T cells. J. Exp. Med. 1997. 185: 2133-2141.
9. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S. and Steinman, R. M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J. Exp. Med. 1992. 176: 1693-1702.
10. Chambers, B. J., Salcedo, M. and Ljunggren, H.-J., Triggering of natural killer cells by the costimulatory molecule CD80 (B7.1). Immunity 1996. 5: 311-317.
11. Colonna, M., Natural killer cell receptors specific for MHC class I molecules. Curr. Opin. Immunol. 1996. 8: 101-107.
12. Burshtyn, D. N. and Long, E. O., Regulation through inhibitory receptors: lessons from natural killer cells. Trends Cell Biol. 1997. 7: 473-479.
13. Mason, L. H., Ortaldo, J. R., Young, H. A., Kumar, V., Bennett, M. and Anderson, S. K., Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly49 gene family (Ly49G2). J. Exp. Med. 1995. 182: 293-303.
14. Stoneman, E. R., Benett, M., An, J., Chesnut, K. A., Wakeland, E. K., Sheerer, J. B., Siciliano, M. J., Kumar, V. and Mathew, P. A., Cloning and characterization of 5E6 (Ly49C) a receptor molecule expressed on a subset of murine natural killer cells. J. Exp. Med. 1995. 182: 305-313.
15. Yu, Y. Y. L., George, T., Dorfman, J. R., Roland, J., Kumar, V. and Benett, M., The role of Ly49A and 5E6 molecules in hybrid resistance mediated by murine natural killer cell against normal T cell blasts. Immunity 1996. 4: 67-76.
16. Inaba, K., Metlay, J. P., Crowley, M. T. and Steinman, R. M., Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 1990. 172: 631-636.
17. Cayeux, S., Richter, G., Noffz, G., Dörken, B. and Blankenstein, Th., Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J. Immunol. 1997. 158: 2834-2841.
18. Salcedo, M., Andersson, M., Lemieux, S., Van Kaer, L., Chambers, B. J. and Ljunggren, H.-G., Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur. J. Immunol. 1998. 28: 1315-1321.
19. Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D. and Levitsky, H., Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 1994. 264: 961-965.
20. Ossendorp, F., Mengede, E., Camps, M., Filius, R. and Melief, C. J. M., Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J. Exp. Med. 1998. 187: 693-702.
21. Restifo, N. P., Bacik, I., Irvine, K. R., Yewdell, J. W., McCabe, B. J., Anderson, R. W., Eisenlohr, L. C., Rosenberg, S. A. and Bennick, J. R., Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 1995. 154: 4414-4422.
22. Doe, B., Selby, M., Barnett, S., Baenziger, J. and Walker, C. M., Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Nat. Acad. Sci. USA 1996. 93: 8578-8583.
23. Corr, M., Lee, D. J., Carson, D. A. and Tighe, H., Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 1996. 184: 1555-1560.
24. + T cells in vivo. Proc. Nat. Acad. Sci. USA 1994. 91: 3077-3081.
25. Aicher, A., Westermann, J., Cayeux, S., Willimsky, G., Daemen, K., Blankenstein, Th., Uckert, W., Dörken, B. and Pezzutto, A., Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp. Haematol. 1996. 25: 39-44.
26. Hock, H., Dorsch, M., Kunzendorf, U., Ueberla, K., Qin, Z., Diamantstein, T. and Blankenstein, T., Vaccinations with tumor cells genetically engineered to produce different cytokines: effectivity not superior to a classical adjuvant. Cancer Res. 1993. 53: 714-716.
27. Gavin, M. A., Gilbert, M. J., Riddell, S. R., Greenberg, P. D. and Bevan, M.-J., Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes. J. Immunol. 1993. 151: 3971-3980.
28. Oukka, M., Cohen-Tannoudji, M., Tanaka, Y., Babinet, C. and Kosmatopoulos, K., Medullary thymic epithelial cells induce tolerance to intracellular proteins. J. Immunol. 1996. 156(3): 968-975.